4Dos Santos N A G,Rodrigues M A C,Martins N M, et al. Cispla- tin-induced nephrotoxicity and targets of nephroprotection: an update[ J ]. Arch Toxico1,2012,86 ( 8 ) : 1233-1250.
5Boulikas T, Vougiouka M. Cisplatin and platinum drugs at the mo- lecular level (Review) [ J]. Oncol Rep, 2003, 10 (6): 1663-1682.
6Wang Z,Li C,Ellenburg M, et al. Structure of human ferritin L chain [ J ]. Acta Crystallograph Sec D- Biol Crystallograp, 2006, 62(7) :800-806.
7Harrison P M, Arosio P. The ferritins : molecular properties, iron storage function and cellular regulation [ J ]. Biochim Bioph Acta- Bioener, 1996,1275 ( 3 ) : 161-203.
8Arosio P, Ingrassia R, Cavadini P. Ferritins : a family of molecules for iron storage, antioxidation and more [ J ]. Biochim Bioph Acta- General Sub,2009,1790(7) :589-599.
9Cfiehton R R,I-Ierbas A, Chavez-Alba O, et al. Identification of catalytic residues involved in iron uptake by L-chain ferritins [ J ] . J Bio lnorg Chem,1996 ,1( 6 ) :567-574.
10Hempstead P D, Yewdall S J, Fernie A R, et al. Comparison of the three-dimensional structures of recombinant human H and horse L ferritins at high resolution [J ]. J Molecul Biol, 1997,268 (2) :424-448.
